Previous Article | Next Article 
Molecular and Cellular Biology, September 2003, p. 6520-6532, Vol. 23, No. 18
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.18.6520-6532.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Inhibition of Retinoblastoma Protein Degradation by Interaction with the Serpin Plasminogen Activator Inhibitor 2 via a Novel Consensus Motif
Grant A. Darnell,1 Toni M. Antalis,2* Ricky W. Johnstone,3 Brett W. Stringer,4 Steven M. Ogbourne,4 David Harrich,5 and Andreas Suhrbier1*
Australian National Centre for International and Tropical Health and Nutrition,1
Experimental Oncology Program, Queensland Institute of Medical Research and University of Queensland,4
Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Brisbane, Queensland 4029,5
and The Peter MacCallum Cancer Institute, East Melbourne, Victoria 3002, Australia,2
Department of Vascular Biology, Holland Laboratory, American Red Cross, Rockville, Maryland 208553
Received 21 April 2003/
Returned for modification 21 May 2003/
Accepted 10 June 2003
Plasminogen activator inhibitor-2 (PAI-2) is well documented as an inhibitor of the extracellular serine proteinase urokinase-type plasminogen activator (uPA) and is expressed in activated monocytes and macrophages, differentiating keratinocytes, and many tumors. Here we show that PAI-2 has a novel intracellular function as a retinoblastoma protein (Rb)-binding protein. PAI-2 colocalized with Rb in the nucleus and inhibited the turnover of Rb, which led to increases in Rb protein levels and Rb-mediated activities. Although PAI-2 contains an LXCXE motif, Rb binding was primarily mediated by the C-D interhelical region of PAI-2, which was found to bind to the C pocket of Rb. The C-D interhelical region of PAI-2 contained a novel Rb-binding motif, termed the PENF homology motif, which is shared by many cellular and viral Rb-binding proteins. PAI-2 expression also protected Rb from the accelerated degradation mediated by human papillomavirus (HPV) E7, leading to recovery of Rb and inhibition of E6/E7 mRNA expression. Protection of Rb by PAI-2 begins to explain many of the diverse, uPA-independent phenotypes conferred by PAI-2 expression. These results indicate that PAI-2 may enhance Rb's tumor suppressor activity and suggest a potential therapeutic role for PAI-2 against HPV-transformed lesions.
* Corresponding author. Mailing address for Andreas Suhrbier: Queensland Institute of Medical Research, 300 Herston Rd., Herston, Queensland 4029, Australia. Phone: 61-7-33620415. Fax: 61-7-33620107. E-mail:
andreasS{at}qimr.edu.au. Mailing address for Toni M. Antalis: Department of Vascular Biology, Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855. Phone: (301) 738-0658. Fax: (301) 738-0465. E-mail:
antalist{at}usa.redcross.org.
Molecular and Cellular Biology, September 2003, p. 6520-6532, Vol. 23, No. 18
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.18.6520-6532.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Tonnetti, L., Netzel-Arnett, S., Darnell, G. A., Hayes, T., Buzza, M. S., Anglin, I. E., Suhrbier, A., Antalis, T. M.
(2008). SerpinB2 Protection of Retinoblastoma Protein from Calpain Enhances Tumor Cell Survival. Cancer Res.
68: 5648-5657
[Abstract]
[Full Text]
-
Darnell, G. A., Schroder, W. A., Antalis, T. M., Lambley, E., Major, L., Gardner, J., Birrell, G., Cid-Arregui, A., Suhrbier, A.
(2007). Human Papillomavirus E7 Requires the Protease Calpain to Degrade the Retinoblastoma Protein. J. Biol. Chem.
282: 37492-37500
[Abstract]
[Full Text]
-
Darnell, G. A., Schroder, W. A., Gardner, J., Harrich, D., Yu, H., Medcalf, R. L., Warrilow, D., Antalis, T. M., Sonza, S., Suhrbier, A.
(2006). SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication. J. Biol. Chem.
281: 31348-31358
[Abstract]
[Full Text]
-
Fridman, A. L., Tang, L., Kulaeva, O. I., Ye, B., Li, Q., Nahhas, F., Roberts, P. C., Land, S. J., Abrams, J., Tainsky, M. A.
(2006). Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton.. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
61: 879-889
[Abstract]
[Full Text]
-
Engstrom, K., Willen, H., Kabjorn-Gustafsson, C., Andersson, C., Olsson, M., Goransson, M., Jarnum, S., Olofsson, A., Warnhammar, E., Aman, P.
(2006). The Myxoid/Round Cell Liposarcoma Fusion Oncogene FUS-DDIT3 and the Normal DDIT3 Induce a Liposarcoma Phenotype in Transfected Human Fibrosarcoma Cells. Am. J. Pathol.
168: 1642-1653
[Abstract]
[Full Text]
-
Kasyapa, C. S., Kunapuli, P., Hawthorn, L., Cowell, J. K.
(2006). Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease. Blood
107: 3693-3699
[Abstract]
[Full Text]
-
Shellenberger, T. D., Mazumdar, A., Henderson, Y., Briggs, K., Wang, M., Chattopadhyay, C., Jayakumar, A., Frederick, M., Clayman, G. L.
(2005). Headpin: A Serpin with Endogenous and Exogenous Suppression of Angiogenesis. Cancer Res.
65: 11501-11509
[Abstract]
[Full Text]
-
Singh, M., Krajewski, M., Mikolajka, A., Holak, T. A.
(2005). Molecular Determinants for the Complex Formation between the Retinoblastoma Protein and LXCXE Sequences. J. Biol. Chem.
280: 37868-37876
[Abstract]
[Full Text]
-
Jung, J., Kim, T.-g., Lyons, G. E., Kim, H.-R. C., Lee, Y.
(2005). Jumonji Regulates Cardiomyocyte Proliferation via Interaction with Retinoblastoma Protein. J. Biol. Chem.
280: 30916-30923
[Abstract]
[Full Text]
-
Luttge, B. G., Moyer, R. W.
(2005). Suppressors of a Host Range Mutation in the Rabbitpox Virus Serpin SPI-1 Map to Proteins Essential for Viral DNA Replication. J. Virol.
79: 9168-9179
[Abstract]
[Full Text]
-
Darnell, G. A., Antalis, T. M., Rose, B. R., Suhrbier, A.
(2005). Silencing of Integrated Human Papillomavirus Type 18 Oncogene Transcription in Cells Expressing SerpinB2. J. Virol.
79: 4246-4256
[Abstract]
[Full Text]
-
Scarff, K. L., Ung, K. S., Nandurkar, H., Crack, P. J., Bird, C. H., Bird, P. I.
(2004). Targeted Disruption of SPI3/Serpinb6 Does Not Result in Developmental or Growth Defects, Leukocyte Dysfunction, or Susceptibility to Stroke. Mol. Cell. Biol.
24: 4075-4082
[Abstract]
[Full Text]